RxFinder.ai

Futibatinib

LYTGOBI

NADAC/unit N/A
No Shortage Tier 1: 53.8% PA Req: 297.3%

Generic Manufacturers

TAIHO ONCOLOGY INC

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.